138107-58-1
138107-58-1
Chemical Structure
Ro 43-5054
- CAS No.: 138107-58-1
- Formula:C24H27N5O7
- Molecular Weight:497.50
IUPAC Name: (S)-3-(3-(4-carbamimidoylbenzamido)propanamido)-4-(((S)-1-carboxy-2-phenylethyl)amino)-4-oxobutanoic acid
InChIKey: XPXOBWWMCFKOKQ-ROUUACIJSA-N
SMILES: OC([C@H](CC1=CC=CC=C1)NC([C@H](CC(O)=O)NC(CCNC(C2=CC=C(C=C2)C(N)=N)=O)=O)=O)=O
Biological Activity: Ro 43-5054 is a platelet glycoprotein IIb-IIIa receptor antagonist. Ro 43-5054 can be used in the research of early reocclusion after thrombolytic therapy[1].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
Ro 43-5054 | Ro 43-5054 is a platelet glycoprotein IIb-IIIa receptor antagonist. Ro 43-5054 can be used in the research of early reocclusion after thrombolytic therapy. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
References
- [1]. S P Roux, et al. Effects of heparin, aspirin and a synthetic platelet glycoprotein IIb-IIIa receptor antagonist (Ro 43-5054) on coronary artery reperfusion and reocclusion after thrombolysis with tissue-type plasminogen activator in the dog. J Pharmacol Exp Ther. 1993 Jan;264(1):501-8. [Content Brief]
Keywords
